Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Etbmed 150mg Tablet
Manufacturer/Marketed By : MEDICAMEN BIOTECH LTD
$66.48 $27.92
ETBmed 150mg Tablet is an anticancer medicine containing the active constituent erlotinib. It is used to treat non-small lung cancer (NSCLC) and pancreatic cancer. Cancer is a disorder in which...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
ERLOTINIB
Active Pharmaceutical Ingredient
Etbmed 150mg Tablet
66,48$
27,92$
ETBmed 150mg Tablet is an anticancer medicine containing the active constituent erlotinib. It is used to treat non-small lung cancer (NSCLC) and pancreatic cancer. Cancer is a disorder in which cells multiply in an uncontrolled and abnormal manner. It is usually given in combination with another anticancer medicine, gemcitabine, for patients with metastatic or advanced pancreatic cancers. Inform the doctor if you use contact lenses, have an intolerance to sugars, have a history of eye problems, or if any medicines are taken for clotting disorders or cholesterol. The Etbmed 150mg can cause eye dryness and conjunctivitis, and hence, patients are advised to inform the history of vision problems and use contact lenses before taking this medication. ETBmed 150mg Tablet is not recommended for adolescents and children under the age of 18. Do not take this medication with food. Use effective birth control during the treatment and for at least 2 weeks after the last dose. Patients are advised not to smoke while being treated with ETBmed 150mg Tablet, as smoking may decrease the amount of medicine in the blood. Wear protective clothing and sunscreen while going outside. Inform the physician if the patient has any symptoms like pain in the eye, blurred vision, cough, fever, shortness of breath, severe abdominal pain, and persistent diarrhoea while taking this medicine.
Active Pharmaceutical Ingredient
Uses
• Advanced or metastatic non-small lung cancer (NSCLC)
• Advanced or metastatic pancreatic cancer
Benefits
Erlotinib in ETBmed 150mg Tablet prevents the activity of a protein called epidermal growth factor receptor (EFGR), a protein involved in the spread and growth of cancer cells.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. The Inlyta side effects are:
Most Common Side Effects
• Rash worsened in sun-exposed areas
• Loss of appetite decreased weight
• Infection
• Headache
• Depression
• Nausea
• Mouth irritation
• Indigestion
• Hair loss, dry skin, itching, acne, cracked skin
• Tiredness
• Inflammation around fingernail
• Bleeding from nose, stomach, intestines
• Reduced kidney function
Common Side Effects
• Persistent or severe diarrhoea
• Pain in the eye, blurred vision
• Sudden difficulty in breathing accompanied by cough and fever
• Severe pain in your abdomen
• Liver failure
How To Use
Always take this medicine as prescribed by the doctor. The tablet must be taken at least one hour before or two hours after taking food.
Safety Advice
• Breast Feeding: Do not take Etbmed 150 Mg Tablet 30 if you are breastfeeding. Consult the doctor for risks and benefits.
• Alcohol: It is unknown whether it is safe to consume alcohol with ETBmed 150mg Tablet. Please consult your doctor.
• Liver: The Etbmed Erlotinib Tablets are not recommended in patients with severe liver diseases. Inform the physician about any liver disorders.
• Lungs: It is unknown whether ETBmed 150mg Tablet affect the lungs. Please consult your doctor.
• Driving: It is not known whether ETBmed 150mg Tablet alters the ability to drive. Do not drive if you experience symptoms affecting your ability to concentrate and react.
• Pregnancy: Taking ETBmed 150mg Tablet while pregnant can harm the baby. Do not take this medicine during pregnancy unless your doctor recommends taking it. Inform your doctor if you are pregnant or planning to be pregnant before taking this medicine.
Disclaimer
Sidmex Inovia s'efforce de fournir des informations exactes et fiables. Cependant, l'ensemble du contenu de ce site web, y compris les descriptions et compositions des produits, est fourni à titre informatif uniquement et ne saurait se substituer à un avis, un diagnostic ou un traitement médical professionnel.
Il est conseillé aux utilisateurs de consulter un professionnel de santé qualifié avant toute décision médicale. Les informations fournies ne doivent pas être utilisées pour l'autodiagnostic ou l'automédication.
Tous les produits présentés sont exclusivement destinés aux professionnels (B2B) et aux demandes de renseignements en gros. Sidmex Inovia ne promeut pas la consommation directe par les particuliers et vise à soutenir, et non à remplacer, la relation entre le professionnel de santé et le patient.
Les noms de produits, marques et logos appartiennent à leurs propriétaires respectifs et leur utilisation n'implique aucune affiliation ni aucun parrainage. Sidmex Inovia décline toute responsabilité quant aux conséquences découlant de l'utilisation des informations fournies sur ce site web.